Follow The Filings

PCVX position history

The shares of Vaxcyte (PCVX) that MAVERICK CAPITAL LTD reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2024 Q1: 355,131 shares, $24M, 0.46% of portfolio, New
  2. 2024 Q2: 687,908 shares, $52M, 0.99% of portfolio, Add +93.7%
  3. 2024 Q3: 976,249 shares, $112M, 2.2% of portfolio, Add +41.9%
  4. 2024 Q4: 1,201,898 shares, $98M, 1.8% of portfolio, Add +23.1%
  5. 2025 Q1: 1,208,093 shares, $46M, 0.81% of portfolio, Add +0.5%
  6. 2025 Q2: 1,310,605 shares, $43M, 0.64% of portfolio, Add +8.5%
  7. 2025 Q3: 1,289,567 shares, $46M, 0.62% of portfolio, Reduce −1.6%
  8. 2025 Q4: 1,354,237 shares, $62M, 0.67% of portfolio, Add +5.0%
  9. 2026 Q1: 1,377,738 shares, $80M, 0.92% of portfolio, Add +1.7%
  10. 2026 Q2: 1,613,242 shares, $94M, 0.83% of portfolio, Add +17.1%
  11. 2026 Q3: 1,360,031 shares, $77M, 0.60% of portfolio, Reduce −15.7%
Holdings date Value % of holdings Shares Filing date All 13F holders